Novel Progress in Mesothelioma Management
Dr. David Carbone asserts that a revolution in the management of mesothelioma is underway and plenty of doctors confirm it. The move from palliation and hopelessness to groundbreaking scientific advancements has resulted in improved prognosis for patients.
Dr. David Carbone says that as a lung cancer specialist, he feels determined to make a difference in the field of mesothelioma.
Dr. Carbone is an expert on lung cancer and mesothelioma and has contributed to advancements in these fields. He currently serves as medical director for the Ohio State University Medical Center. He leads a program there that brings doctors and scientists together to develop new treatments in treating these diseases.
Dr. Carbone’s Past Work
Previously, Dr. David Carbone served as director for the Vanderbilt-Ingram Cancer Center Experimental Therapeutics Program. It was here that he became the principal investigator for SPORE, a research program on different cancers.
Dr. Carbone has long had an interest in malignant pleural mesothelioma. He says that as a lung cancer specialist, he feels determined to make a difference in the field of mesothelioma. He does so through research, training other doctors, and providing compassionate healthcare to patients. He recognizes that when someone receives a diagnosis of an asbestos-related disease, what they need is compassion and fast-acting treatment to prevent the disease from spreading to the rest of the body.